Hear a diverse panel of small investors (angels and small VCs) from around the world discuss the role of smaller investors in the lifecycle of biotechnology startup companies – both in the US and overseas. The type of companies in which they invest, the stage(s) at which they typically invest, the amount of a typical (or syndicated) investment, and other investment preferences and considerations such as terms, geographies, total funding requirements, and investor ROI will be discussed, compared and contrasted, as will the trajectory of US- vs. non-US-founded and bound companies. Entrepreneurs and other attendees will come away from the session with a better understanding of these sources of funding and their relevance for a diverse array of healthcare companies at various stages of development.